Assignee
BICYCLETX LTD
GB·32 granted patents·40 pending applications·380 citations·filing 2017–2025
Top patents by PatentIndex Score
72 records- 0197US11833211B2Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2BICYCLETX LTD·Filed 2022·Granted Dec 5, 2023·15 cites·20 claims
- 0297US11542304B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2020·Granted Jan 3, 2023·14 cites·20 claims
- 0397US11396530B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Jul 26, 2022·16 cites·22 claims
- 0497US11332500B2Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2020·Granted May 17, 2022·23 cites·21 claims
- 0597US11241473B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Feb 8, 2022·16 cites·27 claims
- 0696US12049520B2Bicyclic peptide ligands specific for CD137BICYCLETX LTD·Filed 2022·Granted Jul 30, 2024·14 cites·24 claims
- 0796US11970553B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2022·Granted Apr 30, 2024·14 cites·21 claims
- 0896US11912792B2Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2022·Granted Feb 27, 2024·14 cites·18 claims
- 0996US11484602B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Nov 1, 2022·16 cites·21 claims
- 1096US11453702B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2021·Granted Sep 27, 2022·16 cites·21 claims
- 1196US11312749B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2020·Granted Apr 26, 2022·24 cites·21 claims
- 1296US11306123B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2020·Granted Apr 19, 2022·24 cites·19 claims
- 1396US11180531B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2019·Granted Nov 23, 2021·18 cites·24 claims
- 1496US10919937B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2019·Granted Feb 16, 2021·29 cites·25 claims
- 1596US10875894B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2019·Granted Dec 29, 2020·26 cites·29 claims
- 1695US11696956B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Jul 11, 2023·18 cites·19 claims
- 1795US11453703B2Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2019·Granted Sep 27, 2022·15 cites·17 claims
- 1895US11261214B2Bicyclic peptide ligand specific for CD137BICYCLETX LTD·Filed 2018·Granted Mar 1, 2022·16 cites·25 claims
- 1995US10857196B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2018·Granted Dec 8, 2020·20 cites·20 claims
- 2094US11730819B2Peptide derivatives having novel linkage structuresBICYCLETX LTD·Filed 2017·Granted Aug 22, 2023·15 cites·23 claims
- 2193US11613560B2Bicyclic peptide ligands specific for OX40BICYCLETX LTD·Filed 2020·Granted Mar 28, 2023·15 cites·26 claims
- 2289US12459974B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2024·Granted Nov 4, 2025·0 cites·11 claims
- 2388US12150998B2Bicyclic peptide ligands specific for P-selectinBICYCLETX LTD·Filed 2022·Granted Nov 26, 2024·1 cites·23 claims
- 2488US2024400616A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 2588US2026000773A1Bicyclic peptide ligands specific for epha2BICYCLETX LTD·Filed 2025·Application pending·0 cites
- 2686US12435107B2Heterotandem bicyclic peptide complexBICYCLETX LTD·Filed 2024·Granted Oct 7, 2025·0 cites·21 claims
- 2785US2024189436A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 2884US2025263438A9Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 2984US2025051392A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 3083US2024000957A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 3180US11866518B2Bicyclic peptide ligands specific for TSLPBICYCLETX LTD·Filed 2021·Granted Jan 9, 2024·1 cites·19 claims
- 3279US2025059236A1Bicyclic peptide ligands specific for cd137BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 3376US2024391959A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 3475US12378288B2Multimeric bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Granted Aug 5, 2025·0 cites·29 claims
- 3573US2021269480A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2019·Application pending·0 cites
- 3673US2025064950A1Bicyclic peptide ligands specific for p-selectinBICYCLETX LTD·Filed 2024·Application pending·0 cites
- 3773US2023340020A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 3872US12570695B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2020·Granted Mar 10, 2026·0 cites·10 claims
- 3972US2025230191A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2025·Application pending·0 cites
- 4071US2025340595A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2025·Application pending·0 cites
- 4167US2023008076A1Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 4267US2022306694A1Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 4367US2025276073A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 4466US11970555B2Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)BICYCLETX LTD·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 4565US12540161B2LinkersBICYCLETX LTD·Filed 2021·Granted Feb 3, 2026·0 cites·21 claims
- 4662US2019389907A1Peptide ligands for binding to mt1-mmpBICYCLETX LTD·Filed 2017·Application pending·0 cites
- 4760US2024398965A1Bicyclic peptide ligand drug conjugatesBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 4858US2024091368A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 4957US2025186539A2Methods for treating cancerBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 5057US2023021419A1Bicyclic peptide ligands specific for il-17BICYCLETX LTD·Filed 2020·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →